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Table 1
Kontrol Distal VTE
Proksimal
VTE PTE P value
NLR 1.800.70 2.731.34 3.221.26 4.101.40 <0.001
WBC 6.50.95 6.61.76 8.22.26 10.12.8 <0.001
Hs-CRP 0.680.35 0.650.35 1.541.33 3.483.95 <0.001
The distribution of NLR, WBC and hs-CRP values between the control group and the sub-
groups of VTE. Abbreviations: NLR, neutrophil to lymphocyte ratio; WBC, white blood cell; hs-
CRP, high-sensitivity C-reactive protein.
Table 1. Baseline characteristics and laboratory ﬁndings of the study groups
Variables
Control group
(n=46)
Risky group
(n=36) P value
Age (years) 13.911.31 14.561.73 0.060
Gender (Male) 26 (57) 20 (56) 0.930
Body mass index
(kg/m2)
19.783.25 20.293.59 0.500
Systolic blood
pressure (mmHg)
111.8512.75 113.3114.73 0.633
Diastolic blood
pressure (mmHg)
69.468.11 72.449.10 0.121
Total cholesterol
(mg/dl)
156.7627.62 165.1235.60 0.403
Triglyceride (mg/dl) 112.3555.16 104.9148.44 0.626
LDL-C (mg/dl) 84.2322.26 93.7632.30 0.282
HDL-C (mg/dl) 63.6513.41 56.5514.95 0.106
Creatinine (mg/dl) 0.490.11 0.510.13 0.644
Fasting glucose
(mg/dl)
87.639.91 90.279.19 0.275
Hemoglobin (g/dl) 12.350.85 12.311.25 0.899
hs-CRP (mg/L) 0.46 [0.24-1.62] 0.36 [0.23-0.75] 0.582
LDL-C low-density lipoprotein cholesterol; HDL high-density lipoprotein cholesterol; hs-CRP
high sensitivity C-reactive protein. Data are shown as n (%), meanSD, median [IQR].
Table 2. Distribution of genotype and allele frequencies and odds ratios and
95% conﬁdential intervals of the atherosclerosis risk among CRP, eNOS, and
IL-6 polymorphisms
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CRP +1444 C/T
Genotypes 0.585
C/C 24 (52.2) 16 (44.4)
C/T 19 (41.3) 19 (52.8)
T/T 3 (6.5) 1 (2.8)
Alleles 0.390 1.10 (0.56-2.18)
C 67 (72.8) 51 (70.8)
T 25 (27.2) 21 (29.2)
eNOS -786 T/C
Genotypes 0.502
T/T 28 (60.9) 18 (50.0)
T/C 11 (23.9) 13 (36.1)
C/C 7 (15.2) 5 (13.9)
Alleles 0.255 1.26 (0.64-2.46)
T 67 (72.8) 49 (68.1)
C 25 (27.2) 23 (31.9)
IL-6 -572 G/C
Genotypes 0.012
G/G 42 (91.3) 25 (69.4)
G/C 3 (6.5) 10 (27.8)
C/C 1 (2.2) 1 (2.8)
Alleles 0.012 3.48 (1.17-10.32)
G 87 (94.5) 60 (83.3)
C 5 (5.4) 12 (16.6)
CRP C-reactive protein, NOS nitric oxide synthase, IL-6 interleukin-6. Data are shown as n (%).
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Objectıve: The aim of this study was to investigate the relationship between the
anatomic extent of venous thromboembolism (VTE) and nonspeciﬁc inﬂammatoryC126 JACC Vomarkers such as Neutrophil to lymphocyte ratio (NLR) and high-sensitivity C-reactive
protein (hs-CRP).
Methods: We retrospectively enrolled 77 patients with VTE (Distal deep vein
thrombosis (DVT) (n¼19), proximal DVT (n¼32) and pulmonary thomboembolism
(PTE) (n¼26)) and 34 healthy controls. Distal and proximal DVT was diagnosed by
using peripheral vascular duplex ultrasonography. Proximal DVT was deﬁned as
thrombosis at the level of the popliteal veins or above. Distal DVT was deﬁned as
thrombosis occurring within the calf veins. The diagnosis of PTE was conﬁrmed in all
cases by computed tomography. Total and differential leukocyte count and hs-CRP
were determined by standard laboratory.
Results: It was detected in patients with VTE that WBC (8.50.26 vs 6.50.95,
p<0.001), NLR (3.411.41 vs 1.800.70, p<0.001) and hs-CRP(2.002.68 mg/L vs
0.680.35 mg/L, p¼0.005) levels were signiﬁcantly higher in comparison with the
healthy control group. According to the analysis made by ANOVA, the levels of
WBC, NLR and hs-CRP were clearly different among the groups (control, distal and
proximal DVT and PTE) (p<0.001). According to ANOVA test with LSD as a post-
hoc test performed to ﬁnd the source of the difference between the groups, only hs-
CRP was found high in PTE group in comparison with the other groups; and no
difference was detected between the other groups. A signiﬁcant increase from the
control group to DVT and PTE was observed in the analysis made for NLR. In the
analysis for WBC, while there was no difference between the control group and distal
DVT, it was found signiﬁcantly higher in the proximal DVT and PTE (Table 1). ROC
curve analysis was performed in order to ﬁnd the best cut-off values of these variables
in predicting VTE. AUC:0.849, p<0.001 was detected for NLR>1.84. For this value,
sensitivity as 88.2% and speciﬁty as 67.6% was determined. AUC:0.741, p<0.001
was detected for Hs-CRP>1.17. For this value, sensitivity as 45.6% and speciﬁty as
94.1% was determined. For WBC>7.7, AUC:0.761, p<0.001 was detected. For this
value, sensitivity as 57.4% and speciﬁty as 91.2% was determined. ROC curve-AUC
values of each three variables were compared. While there was no signiﬁcant
difference between hs-CRP and WBC (p¼0.742), it was observed that there was
a clear difference between both NLR and WBC (p¼0.078), and NLR and hs-CRP
(p¼0.044) (Figure 1).
Conclusıons: These ﬁndings suggest that the inﬂammatory process might have an
important role in the prothrombotic state in patients with VTE. Also, NLR may be
effective in determining the anatomic extent of VTE. NLR is inexpensive and
readily available markers that may be useful for risk stratiﬁcation in patients with
VTE.PP-113
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Objectıve: The coexisting clinical, echocardiographic and biochemical risk factors
have been identiﬁed in relation to an increased risk of thromboembolism in patientsl 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS
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Swith atrial ﬁbrillation (AF). Serum uric acid (SUA) is the end product of purine
metabolism catalyzed by xanthine oxidoreductase, which has been found in the left
atrium of patients with AF, and increased SUA level could be a sign of oxidative
damage and inﬂammation, which play a role in the pathogenesis of AF. Although it
has been demonstrated that SUA level is tend to be higher in patients with AF, the
relationship between the contractile function of left atrial appendage (LAA) and SUA
level has not been fully elucidated. However, elevated SUA level may be an additional
cumulative risk factor for increased thromboembolic events in patients with AF. We
aimed to examine the relationship between SUA level and contractile function of LAA
in a short cohort of patients with AF.
Materıal-Methods: One hundred thirty patients with AF in whom transesophageal
echocardiography was performed to guide the decision about when to perform
cardioversion were enrolled to this study. Patients were categorized according to
their blood ﬂow velocity of the LAA. Group 1 was consisted of 68 patients with
low LAA ﬂow velocity (<35 cm/s) and group 2 was consisted of 62 patients with
normal LAA ﬂow velocity (35 cm/s). Statistical analyses (Independent-Samples
T test and Chi-Square tests) were used to evaluate the differences between two
groups.
Results: The blood ﬂow velocity of LAA was 24.825.75 cm/sn in group 1 and
48.4112.68 cm/sn in group 2 (p value < 0.001). Although there was no difference
for the presence of thrombi in the LAA between two groups, spontaneous echo
contrast was more prominent in patients with group 2 (p value <0.001). Also, we
found that AF patients with low blood ﬂow velocity were composed of older patients
(p value 0.013). We found a statistically signiﬁcant difference for SUA between two
groups (7.111.89 mg/dl for group 1 and 6.071.49 mg/dl for group 2, p value
0.001). SUA levels were positively correlated with left atrial diameter (r¼0.336, p
value 0.008) and there was a negative correlation between SUA and blood ﬂow
velocity of LAA (r¼-0.256, p value 0.003). (Table 1).
Conclusıon: The measurement of SUA is a simple, easily determined marker of
inﬂammation and oxidative stress at a low cost. Elevated SUA levels may be asso-
ciated with the decreased contractile function of LAA and may provide additional
prognostic information with future thromboembolic events in patients with AF.
However, it is controversial whether an elevated SUA is a cause or a consequence of
decreased contractile function of LA and/or LAA. Further randomized, prospective,
large-scale studies are needed to elucidate the exact pathophysiologic and prognostic
role of SUA in this setting and assess its potential clinical relevance.Results of the Study
GROUP 1 (n=68) GROUP 2 (n=62) P value
Age, years 68.54  9.39 63.09  14.87 0.013
Male, n (%) 36 (52.9%) 46 (74.2%) 0.018
CAD, n (%) 25 (36.8%) 20 (32.3%) 0.712
HT, n (%) 33 (48.5%) 21 (33.9%) 0.110
HL, n (%) 17 (25%) 10 (16.1%) 0.280
DM, n (%) 9 (13.2%) 9 (14.5%) 1.000
Heart rate (bmp) 90.45  21.93 92.12  18.06 0.638
DBP (mmHg) 71.14  13.28 73.95  12.65 0.465
SBP (mmHg) 123.82  21.75 124.45  24.45 0.926
Blood ﬂow velocity of
LAA (cm/sn)
24.82  5.75 48.41  12.68 < 0.001
SEC, n (%) 44 (67.6%) 14 (22.6%) < 0.001
LAA Thrombus, n (%) 14 (20.6%) 6 (9.7%) 0.095
LVIDd, (mm) 51.20  6.04 49.42  8.39 0.363
IVSd, (mm) 11.03  2.36 10.33  2.16 0.316
LA, (mm) 47.64  9.26 41.67  7.62 0.008
LVEF, (%) 49.02  11.89 53.05  14.53 0.224
Glucose, (mg/dl) 106.42  24.54 120.25  51.74 0.059
Urea, (mg/dl) 47.31  32.46 39.04  13.37 0.064
Creatinine, (mg/dl) 1.17  0.34 1.08  0.28 0.108
Uric Acid, (mg/dl) 7.11  1.89 6.07  1.49 0.001
HDL-C, (mg/dl) 43.41  13.56 45.46  14.72 0.409
LDL-C, (mg/dl) 107.42  33.50 113.15  33.84 0.334
TG, (mg/dl) 135.20  91.41 139.59  75.30 0.767
Total-C, (mg/dl) 176.05  44.47 187.29  47.23 0.165
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Introductıon: Recent studies identiﬁed possible roles of oxidative stress and
increased inﬂammatory status in the pathogenesis of ascending aortic dilatation. High
serum gamma-glutamyltransferase (GGT) levels indicate a marker of oxidative
stress.GGT level is positively associated with the development of hypertension. In this
study we aimed to eveluate the relation between serum GGT levels and assendan aort
dilatation.
Method: There were 79 patients enrolled whose assendan aorta was measured with
two dimentional ecocardiography and classiﬁed to two groups as those with dilated
assendan aorta n:36 and those with a normal aortic diameter n:43. We have measured
the GGT,CRP,glucose,uric ascit levels and lipid prophyl in th blood samples of the
patients mentioned.
Results: Serum GGT and CRP levels were signiﬁcantly higher in those patients with
dilated assendan aorta (p:0,001 and p:0,01 respectively). Also hypertention and dia-
betes mellitus frequency was signiﬁcanly higher in the same group (p:0,001 and p:
0,002 respectively). Statisticely positive correlation was showen with serum CRP
(r¼0.3, p¼0.006),GGT (r¼0.4, p¼0.01) levels and assenden aorta diameter. Logistic
regression analysis showed that HT,GGT and DM were independent predictors for
dilatation of assendan aorta.
Conclusıon: Serum GGT levels were higher in those patients with dilated assendan
aorta. Likewise the other studies our study showed that serum GGT levels are
considerable for the patogenesis of HT also can lead to aortic dilatation via causing
oxidative stress and inﬂammatuary stress responce.
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Background and Aim: Atrial ﬁbrillation (AF) and presence of prosthetic valve are
common comorbidities that necessitate warfarin treatment. The risk of complication
increases when INR (International normalized ratio) values are out of therapeutic
range. Mean time in therapeutic range (TTR) below 60% indicates that warfarin is
inefﬁcient. In our study, we aimed to determine TTR values in patients who were on
warfarin treatment and had valvular AF, nonvalvular AF and prosthetic valve. We also
aimed to identify the factors affecting TTR in these patients.
Method: Among patients admitted to out-patient clinics between June 2012 and
December 2012, we enrolled 248 patients who were on warfarin treatment for
valvular-nonvalvular AF or prostethic valve. TTR values of patients were
calculated by using linear interpolation method. A cut off value of 60% was used
to assess efﬁciency of TTR. Patients were classiﬁed into two groups according to
their TTR values (60% vs. <60%) and the characteristic features of these
groups were compared. Patients were classiﬁed further into three groups
according to their indications for warfarin (valvular AF, nonvalvular AF and
prostethic valve). HASBLED score was used to identify tendency for bleeding
complication. Weekly warfarin dosage and duration of warfarin use were noted
for each patient.
Results: The mean age of the patients was 57.21  12.45 years and 66.9% of the
patients were female. Mean TTR value was 55.92  27.84% and 48% of the patients
had TTR values above 60% threshold. There was no statistical difference among
nonvalvular AF, valvular AF and prosthetic valve groups in terms of TTR values and
TTR efﬁciency (p:0.668 and p:0.901, respectively). We did not ﬁnd any clinical and
demographic differences between two TTR groups (TTR 60% vs. < 60%). The
patients with nonvalvular AF were older (p< 0.001), had higher prevalence of
coronary artery disease and hypertension (p:0.004 and p:0.001, respectively). The
bleeding scores were higher while total warfarin doses were lower in nonvalvular AF
group (p:0.03 and p:0.004, respectively). The percentage of patients with a history of
previous thromboembolic or bleeding complications and the duration of warfarin use
were higher in the prosthetic valve group (p:0.027 and p:<0.001, respectively). The
mean TTR value did not differ according to socioeconomic status and comorbidities.
There was no relationship between the presence of a previous complication and TTR
(p:0.995).
Conclusıons: In our study, we found that our study subjects had low TTR values and
that TTR values were not associated with the indication for warfarin or with the
characteristics of the patients.ERS C127
